The National COVID Cohort Collaborative (N3C): Rationale, Design, Infrastructure, and Deployment M Haendel, C Chute, K Gersing, et al Journal of the American Medical Informatics Association, 2020 | 410 | 2020 |
Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the US National COVID Cohort Collaborative TD Bennett, RA Moffitt, JG Hajagos, B Amor, A Anand, MM Bissell, ... JAMA network open 4 (7), e2116901-e2116901, 2021 | 184 | 2021 |
Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled … JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... MedRxiv, 2020 | 178 | 2020 |
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis DR Morales, MM Conover, SC You, N Pratt, K Kostka, T Duarte-Salles, ... The Lancet Digital Health 3 (2), e98-e114, 2021 | 146 | 2021 |
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study JCE Lane, J Weaver, K Kostka, T Duarte-Salles, MTF Abrahao, H Alghoul, ... The Lancet Rheumatology 2 (11), e698-e711, 2020 | 127 | 2020 |
Identifying who has long COVID in the USA: a machine learning approach using N3C data ER Pfaff, AT Girvin, TD Bennett, A Bhatia, IM Brooks, RR Deer, ... The Lancet Digital Health 4 (7), e532-e541, 2022 | 122 | 2022 |
Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous … AK Chakrabarti, K Feeney, C Abueg, DA Brown, E Czyz, M Tendera, ... American heart journal 165 (4), 509-514. e7, 2013 | 91 | 2013 |
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study E Burn, SC You, AG Sena, K Kostka, H Abedtash, MTF Abrahão, ... Nature communications 11 (1), 5009, 2020 | 89 | 2020 |
Coding long COVID: characterizing a new disease through an ICD-10 lens ER Pfaff, C Madlock-Brown, JM Baratta, A Bhatia, H Davis, A Girvin, E Hill, ... BMC medicine 21 (1), 58, 2023 | 78 | 2023 |
Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes JT Reese, H Blau, E Casiraghi, T Bergquist, JJ Loomba, TJ Callahan, ... EBioMedicine 87, 2023 | 78 | 2023 |
Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study E Burn, T Duarte-Salles, S Fernandez-Bertolin, C Reyes, K Kostka, ... The Lancet Infectious Diseases 22 (8), 1142-1152, 2022 | 76 | 2022 |
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study A Prats-Uribe, AG Sena, LYH Lai, H Alghoul, O Alser, TM Alshammari, ... bmj 373, 2021 | 65 | 2021 |
The national COVID cohort collaborative: clinical characterization and early severity prediction TD Bennett, RA Moffitt, JG Hajagos, B Amor, A Anand, MM Bissell, ... MedRxiv, 2021 | 59 | 2021 |
Thirty-day outcomes of children and adolescents with COVID-19: an international experience T Duarte-Salles, D Vizcaya, A Pistillo, P Casajust, AG Sena, LYH Lai, ... Pediatrics 148 (3), 2021 | 54 | 2021 |
Association of early aspirin use with in-hospital mortality in patients with moderate COVID-19 JH Chow, A Rahnavard, M Gomberg-Maitland, R Chatterjee, P Patodi, ... JAMA network open 5 (3), e223890-e223890, 2022 | 47 | 2022 |
Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network RD Williams, AF Markus, C Yang, T Duarte-Salles, SL DuVall, T Falconer, ... BMC Medical Research Methodology 22 (1), 35, 2022 | 46 | 2022 |
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries EH Tan, AG Sena, A Prats-Uribe, SC You, WUR Ahmed, K Kostka, ... Rheumatology 60 (SI), SI37-SI50, 2021 | 46 | 2021 |
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID‐19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient … E Burn, X Li, K Kostka, HM Stewart, C Reich, S Seager, T Duarte‐Salles, ... Pharmacoepidemiology and Drug Safety 31 (5), 495-510, 2022 | 42 | 2022 |
Synergies between centralized and federated approaches to data quality: a report from the national COVID cohort collaborative ER Pfaff, AT Girvin, DL Gabriel, K Kostka, M Morris, MB Palchuk, ... Journal of the American Medical Informatics Association 29 (4), 609-618, 2022 | 41 | 2022 |
National COVID Cohort Collaborative (N3C) Consortium. Clinical characterization and prediction of clinical severity of SARS-CoV-2 infection among US adults using data from the … TD Bennett, RA Moffitt, JG Hajagos, B Amor, A Anand, MM Bissell, ... JAMA Netw Open 4 (7), e2116901, 2021 | 36 | 2021 |